These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38014106)

  • 1. Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.
    Codocedo JF; Mera-Reina C; Lin PB; Puntambekar SS; Casali BT; Jury N; Martinez P; Lasagna-Reeves CA; Landreth GE
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progression.
    Codocedo JF; Mera-Reina C; Bor-Chian Lin P; Fallen PB; Puntambekar SS; Casali BT; Jury-Garfe N; Martinez P; Lasagna-Reeves CA; Landreth GE
    Cell Rep; 2024 Jul; 43(7):114488. PubMed ID: 39002124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease.
    Fairley LH; Lai KO; Wong JH; Chong WJ; Vincent AS; D'Agostino G; Wu X; Naik RR; Jayaraman A; Langley SR; Ruedl C; Barron AM
    Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2209177120. PubMed ID: 36787364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.
    Leng L; Yuan Z; Pan R; Su X; Wang H; Xue J; Zhuang K; Gao J; Chen Z; Lin H; Xie W; Li H; Chen Z; Ren K; Zhang X; Wang W; Jin ZB; Wu S; Wang X; Yuan Z; Xu H; Chow HM; Zhang J
    Nat Metab; 2022 Oct; 4(10):1287-1305. PubMed ID: 36203054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of hexokinase 2 in shaping microglial function by gating glycolytic flux and mitochondrial activity.
    Hu Y; Cao K; Wang F; Wu W; Mai W; Qiu L; Luo Y; Ge WP; Sun B; Shi L; Zhu J; Zhang J; Wu Z; Xie Y; Duan S; Gao Z
    Nat Metab; 2022 Dec; 4(12):1756-1774. PubMed ID: 36536134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
    Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
    Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAC Transgenic Expression of Human TREM2-R47H Remodels Amyloid Plaques but Unable to Reprogram Plaque-associated Microglial Reactivity in 5xFAD Mice.
    Lee CYD; De La Rocha AJ; Inouye K; Langfelder P; Daggett A; Gu X; Jiang LL; Pamonag Z; Vaca RG; Richman J; Kawaguchi R; Gao F; Xu H; Yang XW
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired microglial glycolysis promotes inflammatory responses after intracerebral haemorrhage via HK2-dependent mitochondrial dysfunction.
    Li Y; Zhou H; He X; Jin L; Zhu Y; Hu L; Feng M; Zhu J; Wang L; Zheng Y; Li S; Yan Z; Cen P; Hu J; Chen Z; Yu X; Fu X; Xu C; Cao S; Cao Y; Chen G; Wang L
    J Adv Res; 2024 Aug; ():. PubMed ID: 39142439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease.
    Daily KP; Badr A; Eltobgy M; Estfanous S; Whitham O; Tan MH; Carafice C; Krause K; McNamara A; Hamilton K; Houle S; Gupta S; Gupta GA; Madhu S; Fitzgerald J; Saadey AA; Laster B; Yan P; Webb A; Zhang X; Pietrzak M; Kokiko-Cochran ON; Ghoneim HE; Amer AO
    Alzheimers Res Ther; 2024 Feb; 16(1):29. PubMed ID: 38326859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.
    Terzioglu G; Young-Pearse TL
    Mol Neurodegener; 2023 Nov; 18(1):89. PubMed ID: 38017562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexokinase 2-dependent hyperglycolysis driving microglial activation contributes to ischemic brain injury.
    Li Y; Lu B; Sheng L; Zhu Z; Sun H; Zhou Y; Yang Y; Xue D; Chen W; Tian X; Du Y; Yan M; Zhu W; Xing F; Li K; Lin S; Qiu P; Su X; Huang Y; Yan G; Yin W
    J Neurochem; 2018 Jan; 144(2):186-200. PubMed ID: 29205357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGE-TXNIP axis drives inflammation in Alzheimer's by targeting Aβ to mitochondria in microglia.
    Sbai O; Djelloul M; Auletta A; Ieraci A; Vascotto C; Perrone L
    Cell Death Dis; 2022 Apr; 13(4):302. PubMed ID: 35379773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
    Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
    Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
    Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
    Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alzheimer's disease-associated gene
    Wang SY; Fu XX; Duan R; Wei B; Cao HM; Yan E; Chen SY; Zhang YD; Jiang T
    Neural Regen Res; 2023 Feb; 18(2):434-438. PubMed ID: 35900442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway.
    Jung ES; Suh K; Han J; Kim H; Kang HS; Choi WS; Mook-Jung I
    Aging Cell; 2022 May; 21(5):e13623. PubMed ID: 35474599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer's disease.
    Ng RC; Jian M; Ma OK; Xiang AW; Bunting M; Kwan JS; Wong CW; Yick LW; Chung SK; Lam KS; Alexander IE; Xu A; Chan KH
    J Neuroinflammation; 2024 Mar; 21(1):77. PubMed ID: 38539253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease.
    Fairley LH; Wong JH; Barron AM
    Front Immunol; 2021; 12():624538. PubMed ID: 33717134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.